Under construction – not a live service
Sign in
Taking people in AustriaNo phase

Database Recording Health Data of Adults With Pulmonary Hypertension

Collects health and medical history of adults with high lung blood pressure.

Plain-language title generated from the registry record
Registry title: Database for Clinical and Anamnestic Data in Pulmonary Hypertension

Key facts

Where
Graz, AustriaSee the site

Where in Austria

  • Medical University of GrazGraz, AustriaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical University of Graz
Trial code
NCT01607502
Record updated
15 January 2026
Original description
Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization.Read full original descriptionShow less

Database for Clinical and Anamnestic Data in Pulmonary Hypertension

Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization.

There are different forms of PH defined in the classification of Dana Point 2008.

PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like the echocardiography, stress echocardiography and cardio pulmonary exercise testing. In the diagnosis process and in the follow up of PH patients biomarkers like NTproBNP are helpful. There are no specific biomarkers for the disease which can make the diagnosis process easier and predict prognosis.

The systematic data collection in a data base provides better information about patients in daily routine and clinical studies as well as in the design of new studies.

Inclusion: patients with pulmonary hypertension; patients at risk for getting pulmonary hypertension; patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent.

Exclusion: patients without written informed consent.

ClinicalTrials.gov NCT01607502